v.231201
Showing details for project SYSMHC00059
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00059_HLA-A549 | 3 | Human | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | ||
| SYSMHC00059_HLA-A549-SarsCoV | 3 | Human | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | ||
| SYSMHC00059_HLA-HEK293 | 3 | Human | HLA-A02:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00059_HLA-HEK293-SarsCoV | 3 | Human | HLA-A02:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00059_HLA_A549_12h | 3 | Human | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | ||
| SYSMHC00059_HLA_A549_18h | 3 | Human | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | ||
| SYSMHC00059_HLA_A549_24h | 3 | Human | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | ||
| SYSMHC00059_HLA_HEK293_12h | 3 | Human | HLA-A02:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00059_HLA_HEK293_18h | 3 | Human | HLA-A02:01,HLA-B07:02,HLA-C07:02 | ||
| SYSMHC00059_HLA_HEK293_24h | 3 | Human | HLA-A02:01,HLA-B07:02,HLA-C07:02 |
Detailed view of sample SYSMHC00059_HLA_A549_12h
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00059 | SYSMHC00059_HLA_A549_12h | VP20200710_FAIMS_unit20312_SK_HLA_A549_SarsCoV2infected_12h_fxn01.raw | Human | In vitro | Lung | Adenocarcinoma cell | adherent | Lung non-small cell cancer | class I | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | 34171305 | native | Immunoaffinity | W6/32 | Q-Exactive | EasyNanoLC 1200 | no | DDA | HCD | 1 | ||||
| SYSMHC00059 | SYSMHC00059_HLA_A549_12h | VP20200710_FAIMS_unit20312_SK_HLA_A549_SarsCoV2infected_12h_fxn02.raw | Human | In vitro | Lung | Adenocarcinoma cell | adherent | Lung non-small cell cancer | class I | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | 34171305 | native | Immunoaffinity | W6/32 | Q-Exactive | EasyNanoLC 1200 | no | DDA | HCD | 2 | ||||
| SYSMHC00059 | SYSMHC00059_HLA_A549_12h | VP20200710_FAIMS_unit20312_SK_HLA_A549_SarsCoV2infected_12h_fxn03.raw | Human | In vitro | Lung | Adenocarcinoma cell | adherent | Lung non-small cell cancer | class I | HLA-A25:01,HLA-A30:01,HLA-B18:01,HLA-B44:03,HLA-C12:03,HLA-C16:01 | 34171305 | native | Immunoaffinity | W6/32 | Q-Exactive | EasyNanoLC 1200 | no | DDA | HCD | 3 |